US case against ban on therapeutic cloning gains support
This article was originally published in Clinica
In its recent report calling on the US to bar human reproductive cloning for five years, the National Academy of Sciences (NAS) recommended that cloning for medical purposes be allowed to continue, given the promise it holds in being able to treat a host of diseases.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.